Amira H. Kamal
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Amira H. Kamal has a total of 35 co-authors. Here are the top co-authors by number of shared publications:
Sherin F. Hammad
Department of Pharmaceutical Analytical Chemistry, Faculty of Pharmacy, Tanta University, Tanta, Egypt
8 shared publications- Fotouh Rashed Mansour
Department of Medicinal Chemistry, Faculty of Pharmacy, King Salman International University (KSIU), Ras Sudr 46612, Egypt
6 shared publications - Sherin Farouk Hammad
Pharmaceutical Analytical Chemistry Department, Faculty of Pharmacy, Tanta University, Tanta, Egypt
5 shared publications Ahmed A. Habib
Department of Pharmaceutical Analytical Chemistry, Faculty of Pharmacy, Tanta University, Tanta, Egypt
4 shared publicationsDoaa N. Kamel
Department of Pharmaceutical Analytical Chemistry, Faculty of Pharmacy, Tanta University, Tanta, Egypt
4 shared publications- Mohamed Abdelkhalek Hammad
Department of Analytical Chemistry, Faculty of Pharmacy University of Sadat City Sadat City Egypt
4 shared publications
Latest Publications
- 26 September 2026
- Published by Wiley in Luminescence
- Vol. 41 (10) , e70628
Biomass‐Derived Carbon Dots–Based FRAP Analog for Sensitive Evaluation of Antioxidant Activity: Application to Pharmaceutical Products and Plant Extracts
Ferric reducing antioxidant power (FRAP) is a well‐established antioxidant in vitro assay. This work introduces an innovative FRAP‐analog assay based on green‐synthesized carbon dots (GCDs) for the sensitive evaluation of antioxidant activity. The GCDs were prepared via ordinary roasting of sweet potato, which is considered a natural and renewable precursor, yielding highly fluorescent (quantum yield 53%), water‐soluble CDs with excellent ferric (Fe 3+ ) complexing activity. In this system, the addition of Fe 3+ leads to quenching of the fluorescence of GCDs. Antioxidant‐induced reduction of Fe 3+ to Fe 2+ leads to a measurable turn on effect. Using ascorbic acid as a reference antioxidant, the sensor exhibited a linear response between 2 and 14 μg/mL ( R 2 0.996) with a limit of detection of 0.82 μg/mL, very good accuracy (recovery = 103.27% ± 3.48%) and acceptable precision (RSD = 1.01%–5.61%). The developed assay was applied successfully to pharmaceutical products and plant extracts. The GCD‐based FRAP analog demonstrated strong correlation with traditional FRAP assays. The devised approach eliminated the use of toxic nonrenewable reagents, rendering it excellent green on both analytical Eco‐scale, Analytical GREEnness (AGREE), and Nano Eco‐Scale metrics. This green, nanomaterial‐based approach provides a promising alternative for antioxidants' analysis in food and pharmaceuticals.
- 26 September 2026
- Published by Wiley in Luminescence
- Vol. 41 (10) , e70628
Biomass‐Derived Carbon Dots–Based FRAP Analog for Sensitive Evaluation of Antioxidant Activity: Application to Pharmaceutical Products and Plant Extracts
Ferric reducing antioxidant power (FRAP) is a well‐established antioxidant in vitro assay. This work introduces an innovative FRAP‐analog assay based on green‐synthesized carbon dots (GCDs) for the sensitive evaluation of antioxidant activity. The GCDs were prepared via ordinary roasting of sweet potato, which is considered a natural and renewable precursor, yielding highly fluorescent (quantum yield 53%), water‐soluble CDs with excellent ferric (Fe 3+ ) complexing activity. In this system, the addition of Fe 3+ leads to quenching of the fluorescence of GCDs. Antioxidant‐induced reduction of Fe 3+ to Fe 2+ leads to a measurable turn on effect. Using ascorbic acid as a reference antioxidant, the sensor exhibited a linear response between 2 and 14 μg/mL ( R 2 0.996) with a limit of detection of 0.82 μg/mL, very good accuracy (recovery = 103.27% ± 3.48%) and acceptable precision (RSD = 1.01%–5.61%). The developed assay was applied successfully to pharmaceutical products and plant extracts. The GCD‐based FRAP analog demonstrated strong correlation with traditional FRAP assays. The devised approach eliminated the use of toxic nonrenewable reagents, rendering it excellent green on both analytical Eco‐scale, Analytical GREEnness (AGREE), and Nano Eco‐Scale metrics. This green, nanomaterial‐based approach provides a promising alternative for antioxidants' analysis in food and pharmaceuticals.
- Open Access
- 5 February 2025
- Published by Egyptian Knowledge Bank in Journal of Advanced Medical and Pharmaceutical Research
- p. 32-47
Review on strategies for analysis of some Structurally Related Pharmaceutical Compounds: Approach to forced degradation, degradation kinetics and impurity profiling of drugs
Structurally related compounds encounter a challenge in their determination due to similarity in chemical structure thus having very close chemical and/or physical properties. This work presented a review about some structurally related pharmaceutical compounds such as prodrugs in presence of active metabolite and/or inactive metabolite in addition to active pharmaceutical ingredients in existence of possible degradation compounds. This review also included simple approach to how to carry out forced degradation studies including hydrolysis and pH rate profiling of drugs, oxidative degradation, photo-degradation, and thermal degradation studies to develop stability indicating assay method (SIAM). The review discussed degradation kinetics including the determination of degradation reaction order, reaction rate, Half-life (t1/2), and shelf life (t 90%) in addition to applying Arrhenius equation to calculate the activation energy. The review also explained the Relative Response Factor (RRF) applied to study impurity profiling of drugs for analysis of pharmaceutical compounds in presence of its impurities.
- 5 February 2025
- Published by Egyptian Knowledge Bank in Journal of Advanced Medical and Pharmaceutical Research
- p. 32-47
Open AccessReview on strategies for analysis of some Structurally Related Pharmaceutical Compounds: Approach to forced degradation, degradation kinetics and impurity profiling of drugs
Structurally related compounds encounter a challenge in their determination due to similarity in chemical structure thus having very close chemical and/or physical properties. This work presented a review about some structurally related pharmaceutical compounds such as prodrugs in presence of active metabolite and/or inactive metabolite in addition to active pharmaceutical ingredients in existence of possible degradation compounds. This review also included simple approach to how to carry out forced degradation studies including hydrolysis and pH rate profiling of drugs, oxidative degradation, photo-degradation, and thermal degradation studies to develop stability indicating assay method (SIAM). The review discussed degradation kinetics including the determination of degradation reaction order, reaction rate, Half-life (t1/2), and shelf life (t 90%) in addition to applying Arrhenius equation to calculate the activation energy. The review also explained the Relative Response Factor (RRF) applied to study impurity profiling of drugs for analysis of pharmaceutical compounds in presence of its impurities.
- 16 January 2025
- Published by Wiley in Luminescence
- Vol. 40 (1) , e70089
Fabrication of Highly Fluorescent Nitrogen and Phosphorus Dual‐Doped Carbon Dots for Selective Sensing of Rutin
Based on nitrogen and phosphorus co‐doped carbon dots (NP‐CDs), a direct, quick, and selective sensing probe for fluorometric detection of rutin has been developed. Utilizing ethylene diamine tetra acetic acid (EDTA) as a carbon and nitrogen source and diammonium hydrogen phosphate (NH4)2HPO4 as a nitrogen and phosphorus source. The NP‐CDs were synthesized in less than 3 min with a straightforward one‐step microwave pyrolysis process with a high quantum yield (63.8%). After being excited at λ = 360 nm, the produced NP‐CDs displayed a maximum bluish fluorescence at λem of 420 nm. Rutin quenched the fluorescence of the produced NP‐CDs based on the inner filter effect and static quenching processes. Along with the International Council of Harmonization (ICH) requirements, the developed spectrofluorometric method was validated. The linearity range was 0.50–35.00 μg/mL of rutin. The developed NP‐CDs were successfully employed to determine rutin concentrations in marketed tablets. The developed method is quick, simple, consistent, sensitive, and selective, and it does not require expensive chemicals or specialized instruments. This study paves the path for future application of NP‐CD in pharmaceutical analysis.
- 16 January 2025
- Published by Wiley in Luminescence
- Vol. 40 (1) , e70089
Fabrication of Highly Fluorescent Nitrogen and Phosphorus Dual‐Doped Carbon Dots for Selective Sensing of Rutin
Based on nitrogen and phosphorus co‐doped carbon dots (NP‐CDs), a direct, quick, and selective sensing probe for fluorometric detection of rutin has been developed. Utilizing ethylene diamine tetra acetic acid (EDTA) as a carbon and nitrogen source and diammonium hydrogen phosphate (NH4)2HPO4 as a nitrogen and phosphorus source. The NP‐CDs were synthesized in less than 3 min with a straightforward one‐step microwave pyrolysis process with a high quantum yield (63.8%). After being excited at λ = 360 nm, the produced NP‐CDs displayed a maximum bluish fluorescence at λem of 420 nm. Rutin quenched the fluorescence of the produced NP‐CDs based on the inner filter effect and static quenching processes. Along with the International Council of Harmonization (ICH) requirements, the developed spectrofluorometric method was validated. The linearity range was 0.50–35.00 μg/mL of rutin. The developed NP‐CDs were successfully employed to determine rutin concentrations in marketed tablets. The developed method is quick, simple, consistent, sensitive, and selective, and it does not require expensive chemicals or specialized instruments. This study paves the path for future application of NP‐CD in pharmaceutical analysis.
- 17 December 2024
- Published by Elsevier in Microchemical Journal
- Vol. 208
Machine learning and genetic algorithm prediction of high quantum yield carbon quantum dots for chemical analysis
- 17 December 2024
- Published by Elsevier in Microchemical Journal
- Vol. 208
Machine learning and genetic algorithm prediction of high quantum yield carbon quantum dots for chemical analysis
- Open Access
- 29 November 2024
- Published by Springer Nature in BMC Chemistry
- Vol. 18 (1) , 1-13
Decoding the synergy: unveiling gradient boosting regression model for multivariate quantitation of pioglitazone, alogliptin and glimepiride in pure and tablet dosage forms
This study represents a comparison among the performances of four multivariate procedures: partial least square (PLS) and artificial neural networks (ANN) in addition to support vector regression (SVR) and extreme gradient boosting (XG Boost) algorithm for the determination of the anti-diabetic mixture of pioglitazone (PIO), alogliptin (ALG) and glimepiride (GLM) in pharmaceutical formulations with aid of UV spectrometry. Key wavelengths were selected using knowledge-based variable selection and various preprocessing methods (e.g., mean centering, orthogonal scatter correction, and principal component analysis) to minimize noise and improve model precision. XG Boost effectively enhanced computing speed and accuracy by focusing on specific spectral features rather than the entire spectrum, demonstrating its advantages in resolving complex, overlapping spectral data. The independent test results of different models demonstrated that XG Boost outperformed other methods. XG Boost achieved the lowest root mean squared error of prediction (RMSEP) and standard deviation (SD) values across all compounds, indicating minimal prediction error and variability. For PIO, XG Boost recorded an RMSEP of 0.100 and SD of 0.369, significantly better than PLS and ANN. For ALG, XG Boost showed near-perfect performance with an RMSEP of 0.001 and SD of 0.005, outperforming SVR and PLS, which had higher error rates. In the case of GLM, XG Boost also excelled with an RMSEP of 0.001 and SD of 0.018, demonstrating superior precision compared to the much higher errors seen in PLS and ANN. These results highlight XG Boost’s exceptional ability to handle complex, overlapping spectral data, making it the most reliable and accurate model in this study.
- 29 November 2024
- Published by Springer Nature in BMC Chemistry
- Vol. 18 (1) , 1-13
Open AccessDecoding the synergy: unveiling gradient boosting regression model for multivariate quantitation of pioglitazone, alogliptin and glimepiride in pure and tablet dosage forms
This study represents a comparison among the performances of four multivariate procedures: partial least square (PLS) and artificial neural networks (ANN) in addition to support vector regression (SVR) and extreme gradient boosting (XG Boost) algorithm for the determination of the anti-diabetic mixture of pioglitazone (PIO), alogliptin (ALG) and glimepiride (GLM) in pharmaceutical formulations with aid of UV spectrometry. Key wavelengths were selected using knowledge-based variable selection and various preprocessing methods (e.g., mean centering, orthogonal scatter correction, and principal component analysis) to minimize noise and improve model precision. XG Boost effectively enhanced computing speed and accuracy by focusing on specific spectral features rather than the entire spectrum, demonstrating its advantages in resolving complex, overlapping spectral data. The independent test results of different models demonstrated that XG Boost outperformed other methods. XG Boost achieved the lowest root mean squared error of prediction (RMSEP) and standard deviation (SD) values across all compounds, indicating minimal prediction error and variability. For PIO, XG Boost recorded an RMSEP of 0.100 and SD of 0.369, significantly better than PLS and ANN. For ALG, XG Boost showed near-perfect performance with an RMSEP of 0.001 and SD of 0.005, outperforming SVR and PLS, which had higher error rates. In the case of GLM, XG Boost also excelled with an RMSEP of 0.001 and SD of 0.018, demonstrating superior precision compared to the much higher errors seen in PLS and ANN. These results highlight XG Boost’s exceptional ability to handle complex, overlapping spectral data, making it the most reliable and accurate model in this study.
- 19 September 2024
- Published by Elsevier in Microchemical Journal
- Vol. 207, 111667
Tips and Tricks for Applying luminescent carbon dots in chemical Analysis: Recent Advancements, Obstacles, and future Outlook
- 19 September 2024
- Published by Elsevier in Microchemical Journal
- Vol. 207, 111667
Tips and Tricks for Applying luminescent carbon dots in chemical Analysis: Recent Advancements, Obstacles, and future Outlook
- Open Access
- 8 February 2024
- Published by Egyptian Knowledge Bank in Journal of Advanced Medical and Pharmaceutical Research
- p. 34-41
Development and Validation of RP-HPLC Method for Analysis of Counterfeit Clopidogrel
Isocratic RP-HPLC method was developed and validated for the analysis of clopidogrel bisulfate counterfeited with acetyl salicylic acid and applied for the determination of clopidogrel bisulfate in pharmaceutical dosage forms. Clopidogrel bisulfate is commonly counterfeited with acetyl salicylic acid and it is not labeled to contain acetyl salicylic acid due to their similar pharmacological effect in inhibiting platelet aggregation. The mobile phase was composed of potassium dihydrogen phosphate buffer 0.02M (pH 2.8) and methanol 30:70 (v/v). The flow rate was 1.5mL/min. Diode array detector was set at 220 nm. The linearity ranges were 10-70 µg/mL and 6-50 µg/mL for clopidogrel bisulfate and acetyl salicylic acid, respectively. The retention time was 2.5 min and 10.23 min for clopidogrel bisulfate and acetyl salicylic acid, respectively. The method was validated according to ICH guidelines. The developed method was successfully applied for the determination of clopidogrel bisulfate counterfeited with acetyl salicylic acid as well as estimation of clopidogrel bisulfate in its different dosage forms.
- 8 February 2024
- Published by Egyptian Knowledge Bank in Journal of Advanced Medical and Pharmaceutical Research
- p. 34-41
Open AccessDevelopment and Validation of RP-HPLC Method for Analysis of Counterfeit Clopidogrel
Isocratic RP-HPLC method was developed and validated for the analysis of clopidogrel bisulfate counterfeited with acetyl salicylic acid and applied for the determination of clopidogrel bisulfate in pharmaceutical dosage forms. Clopidogrel bisulfate is commonly counterfeited with acetyl salicylic acid and it is not labeled to contain acetyl salicylic acid due to their similar pharmacological effect in inhibiting platelet aggregation. The mobile phase was composed of potassium dihydrogen phosphate buffer 0.02M (pH 2.8) and methanol 30:70 (v/v). The flow rate was 1.5mL/min. Diode array detector was set at 220 nm. The linearity ranges were 10-70 µg/mL and 6-50 µg/mL for clopidogrel bisulfate and acetyl salicylic acid, respectively. The retention time was 2.5 min and 10.23 min for clopidogrel bisulfate and acetyl salicylic acid, respectively. The method was validated according to ICH guidelines. The developed method was successfully applied for the determination of clopidogrel bisulfate counterfeited with acetyl salicylic acid as well as estimation of clopidogrel bisulfate in its different dosage forms.